Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study.-论文-万方医学网

第一作者： Signe,Borgquist

第一单位： Signe Borgquist and Judy E. Garber, Dana-Farber Cancer Institute, Harvard Medical School; Anita Giobbie-Hurder, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute; Richard D. Gelber, IBCSG Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, T.H. Chan Harvard School of Public Health, and Frontier Science and Technology Research Foundation; Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation; Meredith M. Regan, IBCSG Statistical Center, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA; Signe Borgquist, Lund University, Lund, Sweden; Thomas P. Ahern, University of Vermont, Burlington, VT; Marco Colleoni and Aron Goldhirsch, IBCSG and European Institute of Oncology, Milan, Italy; István Láng, IBCSG and National Institute of Oncology, Budapest, Hungary; Marc Debled, Institut Bergonié, Bordeaux, France; Bent Ejlertsen, Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark; Roger von Moos, Cantonal Hospital Graubuenden, Chur; Swiss Group for Clinical Cancer Research and IBCSG; Manuela Rabaglio, IBCSG Coordinating Center and Inselspital, Bern; Beat Thürlimann, Breast Center St. Gallen, Kantonsspital, St. Gallen; Swiss Group for Clinical Cancer Research and IBCSG, Bern, Switzerland; Ian Smith, The Royal Marsden Hospital, London, United Kingdom; and Alan S. Coates, IBCSG and University of Sydney School of Public Health, Sydney, Australia.

作者： Signe,Borgquist ^[1] ; Anita,Giobbie-Hurder ^[1] ; Thomas P,Ahern ^[1] ; Judy E,Garber ^[1] ; Marco,Colleoni ^[1] ; István,Láng ^[1] ; Marc,Debled ^[1] ; Bent,Ejlertsen ^[1] ; Roger,von Moos ^[1] ; Ian,Smith ^[1] ; Alan S,Coates ^[1] ; Aron,Goldhirsch ^[1] ; Manuela,Rabaglio ^[1] ; Karen N,Price ^[1] ; Richard D,Gelber ^[1] ; Meredith M,Regan ^[1] ; Beat,Thürlimann ^[1]

作者单位： Signe Borgquist and Judy E. Garber, Dana-Farber Cancer Institute, Harvard Medical School; Anita Giobbie-Hurder, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute; Richard D. Gelber, IBCSG Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, T.H. Chan Harvard School of Public Health, and Frontier Science and Technology Research Foundation; Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation; Meredith M. Regan, IBCSG Statistical Center, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA; Signe Borgquist, Lund University, Lund, Sweden; Thomas P. Ahern, University of Vermont, Burlington, VT; Marco Colleoni and Aron Goldhirsch, IBCSG and European Institute of Oncology, Milan, Italy; István Láng, IBCSG and National Institute of Oncology, Budapest, Hungary; Marc Debled, Institut Bergonié, Bordeaux, France; Bent Ejlertsen, Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark; Roger von Moos, Cantonal Hospital Graubuenden, Chur; Swiss Group for Clinical Cancer Research and IBCSG; Manuela Rabaglio, IBCSG Coordinating Center and Inselspital, Bern; Beat Thürlimann, Breast Center St. Gallen, Kantonsspital, St. Gallen; Swiss Group for Clinical Cancer Research and IBCSG, Bern, Switzerland; Ian Smith, The Royal Marsden Hospital, London, United Kingdom; and Alan S. Coates, IBCSG and University of Sydney School of Public Health, Sydney, Australia. ^[1]

主题词老年人(Aged);抗胆固醇血症药(Anticholesteremic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);乳腺肿瘤(Breast Neoplasms);化学疗法, 辅助(Chemotherapy, Adjuvant);胆固醇(Cholesterol);无病生存(Disease-Free Survival);双盲法(Double-Blind Method);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);高胆固醇血症(Hypercholesterolemia);乳房切除术, 区段(Mastectomy, Segmental);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);腈类(Nitriles);比例危险度模型(Proportional Hazards Models);放射疗法, 辅助(Radiotherapy, Adjuvant);受体, 雌激素(Receptors, Estrogen);受体, 孕酮(Receptors, Progesterone);他莫昔芬(Tamoxifen);三唑类(Triazoles)

DOI 10.1200/JCO.2016.70.3116

PMID 28380313

发布时间 2018-12-02

检索历史清除

Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study.

Journal of clinical oncology

相似文献

Journal of clinical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study.

Journal of clinical oncology

相似文献

Journal of clinical oncology

相关期刊

检索历史清除